# Apex Pharmaceuticals Inc. – FDA Inspection, Apr 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/apex-pharmaceuticals-inc/acd2cd41-87e3-4b8f-ae9f-2ba918d9aa96
Source feed: FDA_Inspections

> FDA inspection 1086635 of Apex Pharmaceuticals Inc., April 18, 2019. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086635
- Company Name: Apex Pharmaceuticals Inc.
- Inspection Date: 2019-04-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 995863 - 2016-11-08](https://www.keypedia.com/records/fda_inspections/apex-pharmaceuticals-inc/f1381c45-a3bc-412c-9976-f4051d2f6957)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)

Company: https://www.keypedia.com/companies/apex-pharmaceuticals-inc/6e156f16-7c9b-40b7-a267-0c315ab67b38

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c